Related Experiment Videos
Liver resections for metastases from intraabdominal leiomyosarcoma
A N Kalil1, B de Lourdes Pereira, M C Brenner
1Departament of Surgery of Fundação Faculdade Federal de Ciências Médicas de Porto Alegre (FFFCMPA), University of Paris XI.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery
|September 1, 1999
Summary
Liver resection for intraabdominal leiomyosarcoma metastases offers long-term survival for select patients. This surgical therapy showed no mortality and promising outcomes in a small patient group.
Area of Science:
- Surgical Oncology
- Gastrointestinal Oncology
- Hepatobiliary Surgery
Background:
- Intraabdominal leiomyosarcoma can metastasize to the liver.
- Surgical resection is a potential treatment for metastatic disease.
- Limited data exists on liver resection for leiomyosarcoma metastases.
Purpose of the Study:
- To evaluate the safety and efficacy of liver resection for intraabdominal leiomyosarcoma metastases.
- To assess long-term survival outcomes in patients undergoing this procedure.
Main Methods:
- Retrospective review of hepatectomies performed between 1992 and 1996.
- Identification of patients who underwent liver resection for intraabdominal leiomyosarcoma metastases.
- Analysis of surgical indications, perioperative outcomes, and survival data.
Main Results:
- Five liver resections were performed in 3 patients for intraabdominal leiomyosarcoma metastases.
- Indications included single liver metastases without extrahepatic disease.
- No operative mortality was observed; longest survival reached 38 months.
Conclusions:
- Liver resection is a feasible therapeutic option for carefully selected patients with intraabdominal leiomyosarcoma liver metastases.
- This approach can achieve long-term survival in select cases.